V020-5513 Screening compound: N3-[2-(4-methoxyphenyl)ethyl]-6-(3-methylphenyl)-N1-(propan-2-yl)piperidine-1,3-dicarboxamide

V020-5513 Screening compound: N3-[2-(4-methoxyphenyl)ethyl]-6-(3-methylphenyl)-N1-(propan-2-yl)piperidine-1,3-dicarboxamide
V020-5513 Screening compound: N3-[2-(4-methoxyphenyl)ethyl]-6-(3-methylphenyl)-N1-(propan-2-yl)piperidine-1,3-dicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-5513
N3-[2-(4-methoxyphenyl)ethyl]-6-(3-methylphenyl)-N1-(propan-2-yl)piperidine-1,3-dicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-5513

Molecular Formula

C26H35N3O3 (C26 H35 N3 O3)

Compound Name

N3-[2-(4-methoxyphenyl)ethyl]-6-(3-methylphenyl)-N1-(propan-2-yl)piperidine-1,3-dicarboxamide

IUPAC name

N3-[2-(4-methoxyphenyl)ethyl]-6-(3-methylphenyl)-N1-(propan-2-yl)piperidine-13-dicarboxamide

SMILES

CC(C)NC(N(CC(CC1)C(NCCc(cc2)ccc2OC)=O)C1c1cc(C)ccc1)=O

InChI

InChI=1S/C26H35N3O3/c1-18(2)28-26(31)29-17-22(10-13-24(29)21-7-5-6-19(3)16-21)25(30)27-15-14-20-8-11-23(32-4)12-9-20/h5-9,11-12,16,18,22,24H,10,13-15,17H2,1-4H3,(H,27,30)(H,28,31)

InChI Key

FQTHTLIVWMHZGR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19898269

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.508

Distribution Coefficient, logD

4.508

Water Solubility, LogSw

-4.32

Polar Surface Area

57.430

Acid Dissociation Constant (pKa)

13.05

Base Dissociation Constant (pKb)

1.62

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

46.20

V020-5513 in Drug Discovery

Included in Screening Libraries

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Nervous system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V020-5513 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-5513?
Check Price and Availability of V020-5513, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-5513 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-5513
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-5513
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-5513 available by request